The laparoscopic training progression is designed to deliver multiple modes of training with the objective of reinforcing core competencies required for surg...
This video shows LapBand Suturing exercise from the bariatrics training module from the laparoscopic virtual reality simulator, LapSim, by Surgical Science. ...
Animals at a High Risk for Perioperative Hypothermia can Benefit from Temperature Regulation Systems During Surgery
Louisville, KY (PRWEB) November 27, 2013
DRE Veterinary has expanded its line of patient warmers designed to combat anesthesia induced hypothermia. Anesthesia induced hypothermia can lead to wound infection and physiological stresses.
Both of these side effects can elevate blood pressure and heart rate in patients potentially causing long-term harm.
DRE Veterinarys new WarmTouch 6000 Warming Unit features a convective system that circulates heated air according to five different intensity settings. The unit is a lightweight 11.5 pounds and comes with an optional transport cart. The WarmTouch also has an intuitive touch screen and a versatile, durable blanket range, making it convenient for a variety of procedures.
When veterinary patients undergo operations that involve the use of anesthesia, they sometimes have difficulty regulating their own body temperature. Without this regulation, patients can easily slip into a hypothermic state.
This tendency toward anesthesia-induced hypothermia is present in many different kinds of animals, including cats and dogs.
One of the key ways clinicians can reduce the risk of anesthesia induced hypothermia is by maintaining the patients body temperature throughout the procedure, and DREs selection of patient warmers offer medical professionals different options to suit any practice.
Nathan Claypool, the director of DRE Veterinary Health and Science, said the company added new patient warmers to keep with DREs commitment to providing choice and value to customers.
We continually strive to bring our customers products that help them improve care in their practice and their bottom line, Claypool said.
Clinicians can also regulate their patients using circulated water with the Gaymal T/Pump Localized Therapy System. This updated unit provides localized warming and cooling therapy with precise temperature controls. The Gaymal T/Pump modulates for slight temperature changes, features a three-layer safety system, and can be used with regular tap water.
A simpler way to ensure veterinary patients are warm and cozy is using one of the dependable blanket warmers from DRE Veterinarys Comfort Series. DRE Veterinary has nine different styles of blanket warming cabinets that warm blankets quickly and have easy to use digital controls.
About DRE Veterinary
For over 25 years, DRE Veterinary has worked with many of North America's top veterinary facilities and organizations. They provide products and services that make sense, save their client's time and money, and allow veterinary surgeons to do the things they do best. DRE Veterinary is located in Louisville, Ky.
Burlington, MA and Dublin, Ireland (PRWEB) November 11, 2013
Nearly two decades ago, University College Dublin alumnus and serial entrepreneur Duncan Lennox left home for the lure of the Boston technology start-up scene. Today, Qstream, the company he co-founded with a Harvard professor, is returning full circle by establishing its European headquarters and R&D center in Dublin, with plans to use the city as the epicenter for the firms global expansion.
Qstream, which provides mobile sales enablement and analytics for driving high-performance teams, named Trinity College alumnae and technology industry veteran, Louella Morton, as General Manager, Ireland. The company also announced immediate plans to add developers to its primary R&D center in Dublin. The expanded presence comes on the heels of Qstreams recent funding led by Frontline Ventures, with participation by Launchpad Venture Group in Boston, and follows seed financing from Enterprise Ireland and Delta Partners in 2011.
As General Manager and Vice President of International Sales, Louella Morton will spearhead the companys global expansion. With more than 20 years of experience in enterprise software, including senior sales and management positions at Adobe, Deloitte and WBT Systems, Louella brings a proven track record of creating and executing business development strategies, through direct and indirect channels. She holds a degree in computer science from Trinity College.
With industry analysts highlighting the disconnect between yesterdays sales methods and todays information-empowered business buyers, Qstream is poised to address the large and under-served business problem of ensuring that reps are equipped to have value-added conversations with their clients. According to Forrester Research, companies worldwide are spending 19% of their SG&A costs on average in sales support-related activities. But despite these large investments, Forrester indicates that only 36% of B2B buyers believe that their meetings with salespeople are valuable and live up to their expectations.
Boston and Dublin have long been united by a common spirit of innovation. Qstream is another perfect example of the founders, technologies and early-stage funding opportunities that flow between these two cities, said Shay Garvey, co-founder of Frontline Ventures. U.S. technology leaders are increasingly capitalizing on this top innovation center as a gateway to growth, and we are pleased to count Qstream among them.
Developed at Harvard, the Qstream solution is clinically proven to keep sales reps sharp and improve on-the-job performance. Busy reps respond to scenario-based questions in just three minutes using any mobile device. Game mechanics such as scoring and leaderboards ensure user engagement, and a sophisticated analytics engine captures dozens of critical data points and instantly transforms them into actionable insights for sales management, such as opportunities for tailored coaching.
To date,Qstream has delivered more than 180 million questions in nine languages to sales reps and others for product launch support, competitive threat management and response, and strategic business initiatives. With tens of thousands of registered users, Qstreams customers include some of the worlds top brands in life sciences, technology and financial services including Genentech, Boehringer Ingelheim, Intuitive Surgical, Oracle, SunGard, Rackspace and SunTrust.
As a native Dubliner whos worked on both sides of the Atlantic, Im delighted to make this city the springboard for our companys continued growth and success, said Duncan Lennox, CEO and co-founder of Qstream. Its a pleasure to welcome Louella to our experienced management team as well. Her leadership will be instrumental in helping us to increase Qstreams presence here and in key markets around the world.
Developed at Harvard, Qstream helps leaders in dynamic environments keep their teams aligned on vital information and on-the-job practices via a series of daily challenges delivered to any mobile device. By combining game mechanics and social engagement with an adaptive spaced delivery approach, Qstream is easy to use and clinically proven to increase knowledge retention. Real-time data lets managers proactively measure and manage team capabilities. The company is based in Burlington, MA with development offices in Oregon and Dublin, Ireland. To learn more, visit Qstream.com, follow us @Qstream or facebook.com/Qstream.
Wellesley, Mass. (PRWEB) November 11, 2013
The Patient Protection and Affordable Healthcare Act (PPACA) of 2010, will have a significant impact on the market for various medical and assistive technologies. Among its other provisions, the new law imposes a tax on medical devices such as prosthetic limbs, pacemakers, and wheelchairs which will increase the cost of these devices and may decrease their use. Additionally, PPACA contains various other provisions that could have a significant impact on the market for assistive technologies, particularly through changes in Medicare. However, demand for medical and healthcare services, including therapeutic and diagnostic screenings, is expected to rise dramatically in the emerging markets as more individuals acquire coverage and the global economy continues to improve.
Medical device manufacturers, diagnostic developers, and individuals must understand these developments in order to capture new opportunities in both domestic and international markets. BCC Research's technical market research reports provide invaluable insights into this dynamic market.
Use BCC Research reports to:
Gain an overview of a wide range of healthcare market segments, including medical devices, diagnostic and therapeutic tools, and other emerging technologies.
Analyze five-year market trends with data from 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) for the period 2013 to 2018.
Evaluate commercial applications for healthcare products, including medical devices, diagnostic and therapeutic tools, and other emerging technologies.
Assess the impact of industry standards and governmental regulations on both the regional and global markets.
Review comprehensive company profiles of the top industry players and relative market shares for leading companies.
BCC Research's technical healthcare market research reports are intended for marketing and management executives within the medical device industry, suppliers to this industry, venture capital professionals interested in exploring commercialization opportunities, and anyone else who wishes to understand how market factors and technologies interact in this industry.
Recently Published Reports:
HLC076B - Cardiovascular Surgical Devices: Technologies and Global Markets
Whether through disease, congenital defects or loss of cardiac and vascular function, the incidence of cardiovascular disease is growing dramatically, spurring continued growth in cardiovascular surgical procedures. In recent years, new technologies have been developed that make sophisticated therapies accessible for patients in previously underserved locations. Medical advances, aging populations, increasing rates of obesity, and poor nutrition will drive significant growth in this market for the foreseeable future. (October 2013)
HLC142A - Therapies and Diagnostics for Uterine Cancer
According to the American Cancer Society, more than 47,000 new cases of uterine or endometrial, cancer were diagnosed and 8,010 women died from the disease in 2012 alone. While there are currently no approved drugs for endometrial cancer, researchers are examining new drugs, combinations of drugs, and targeted therapies at various stages of pipeline development. Growth in this market is primarily driven by an increase in the prevalence rates of the disease due to the aging population, diabetes, and obesity. (September 2013)
HLC078B - Medical Magnetic Resonance Imaging (MRI): Technologies and Global Markets
As magnetic resonance imaging (MRI) becomes a standard in diagnostic healthcare; innovation, higher tesla strength, new applications, and the development of MRI systems that maximize diagnostic equipment usage will continue to drive growth in this market. In addition, the introduction of MRI technology to previously underserved populations outside of the U.S., Europe, and Japan as well as increased utilization reimbursement rates will provide manufacturers with expanded opportunities for the foreseeable future. (September 2013)
HLC079B - Technologies for Long-Term Care and Home Healthcare: Global Markets
Emerging telehealth and safety-monitoring technologies hold the promise of enormous cost savings for the healthcare system by enhancing the ability of providers to deliver timely intervention prior to a patients deterioration. Consequently, a rapidly aging population, the necessity to cut costs in the delivery of care, and further adoption of technology and broadband connectivity by seniors will fuel future demand for this market. (August 2013)
HLC047D - Disabled and Elderly Assistive Technologies
Increasing numbers of disabled and elderly people are living longer and more-independent lives. These changes have coincided with dramatic shifts in public and professional attitudes toward the disabled and the elderly. Advances in medical science, technology and healthcare, combined with demographic trends, societal evolution and changing attitudes will drive this market over the near term. (June 2013)
HLC154A - Surgical Equipment: Technologies and Global Markets
This technical market research report will provide an overview of the global market for surgical equipment, which is undergoing significant changes with technology innovations such as surgical robotics, the introduction of powered surgical tools, and a significant focus on minimally invasive procedures. (November 2013)
HLC146A - Global Markets and Technologies for Molecular Imaging Devices
This report will provide an overview of the global market for molecular imaging devices, which offers a new dimension to medicine as it evolves toward personalized forms of treatment. (November 2013)
- Current Concepts in Tension Pneumothorax: Field, ED, ICU and Big Screen, Donald
J. Green, MD
from Surgery Grand Rounds
View Details about
The Surgical Technologist Program is accredited by the Commission on Accreditation of Allied Health Education Programs (CAAHEP) in cooperation with the Accre...
Video Rating: 0 / 5
Pomona, Calif. (PRWEB) October 29, 2013
A new mobile spay/neuter vehicle will provide valuable community services while also giving Western University of Health Sciences students vital surgical experience.
WesternUs College of Veterinary Medicine (CVM) unveiled its new Veterinary Ambulatory Community Service (VACS) vehicle Oct. 29, 2013.
The College of Veterinary Medicine received a $ 300,000 grant from PetSmart Charities
New York, NY (PRWEB) October 26, 2013
The Endometriosis Foundation of America (EFA) is hosting its 3rd Annual Nurse Conference; Endometriosis: Getting the Word Out on October 26, 2013, from 8:30 3:30 pm at New York Citys Lenox Hill Hospital. This free educational forum, hosted in collaboration with North Shore/LIJ and Lenox Hill Hospital, is designed for nurses and nurse practitioners, with a unique focus on school-based nurses, to educate them about endometriosis, a disease that affects over 176 million women worldwide.
The EFAs conference delivers it all, from the latest research findings and eye-opening presentations, to engaging, interactive discussions with experts to introduce and update nurses on the latest science-based clinical information and applications. It is a companion to the EFAs High School Endometriosis Educational Outreach Program that places emphasis on the critical importance of early diagnosis and effective intervention.
Endometriosis is a debilitating disease that causes many women to suffer in silence, and can lead to missed hours at work and school, infertility, unnecessary surgeries from misdiagnosis, and the long-term use of many powerful painkillers and hormones, said Mady Schuman, Executive Director of the EFA. The nurses attending the conference operate in such diverse and dynamic environments that offer such excellent networking opportunities. It is the collaborative thinking that continues well beyond the conference that will change the way young women and the medical community at large spread the word about this disease.
This years conference is about treating the whole patient, not just the disease. Alternative therapies to conventional wisdom discussions will include the role nutrition plays in chronic pain management, why misdiagnosis is so common, counseling strategies for assisting patients and the role that acupuncture, physical therapy, yoga and Pilates play in pain management.